Cargando…

PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis

Detalles Bibliográficos
Autores principales: Quartier, P, Brunner, H, Constantin, T, Padeh, S, Calvo, I, Erguven, M, Goffin, L, Hofer, M, Kallinich, T, Oliveira, S, Uziel, Y, Viola, S, Nistala, K, Wouters, C, Lheritier, K, Hruska, J, Abrams, K, Martini, A, Ruperto, N, Lovell, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044930/
http://dx.doi.org/10.1186/1546-0096-11-S2-P169
_version_ 1782319219603406848
author Quartier, P
Brunner, H
Constantin, T
Padeh, S
Calvo, I
Erguven, M
Goffin, L
Hofer, M
Kallinich, T
Oliveira, S
Uziel, Y
Viola, S
Nistala, K
Wouters, C
Lheritier, K
Hruska, J
Abrams, K
Martini, A
Ruperto, N
Lovell, D
author_facet Quartier, P
Brunner, H
Constantin, T
Padeh, S
Calvo, I
Erguven, M
Goffin, L
Hofer, M
Kallinich, T
Oliveira, S
Uziel, Y
Viola, S
Nistala, K
Wouters, C
Lheritier, K
Hruska, J
Abrams, K
Martini, A
Ruperto, N
Lovell, D
author_sort Quartier, P
collection PubMed
description
format Online
Article
Text
id pubmed-4044930
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40449302014-06-19 PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis Quartier, P Brunner, H Constantin, T Padeh, S Calvo, I Erguven, M Goffin, L Hofer, M Kallinich, T Oliveira, S Uziel, Y Viola, S Nistala, K Wouters, C Lheritier, K Hruska, J Abrams, K Martini, A Ruperto, N Lovell, D Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044930/ http://dx.doi.org/10.1186/1546-0096-11-S2-P169 Text en Copyright © 2013 Quartier et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Quartier, P
Brunner, H
Constantin, T
Padeh, S
Calvo, I
Erguven, M
Goffin, L
Hofer, M
Kallinich, T
Oliveira, S
Uziel, Y
Viola, S
Nistala, K
Wouters, C
Lheritier, K
Hruska, J
Abrams, K
Martini, A
Ruperto, N
Lovell, D
PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis
title PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis
title_full PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis
title_fullStr PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis
title_full_unstemmed PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis
title_short PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis
title_sort pres-final-2157: efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044930/
http://dx.doi.org/10.1186/1546-0096-11-S2-P169
work_keys_str_mv AT quartierp presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT brunnerh presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT constantint presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT padehs presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT calvoi presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT erguvenm presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT goffinl presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT hoferm presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT kallinicht presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT oliveiras presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT uziely presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT violas presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT nistalak presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT woutersc presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT lheritierk presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT hruskaj presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT abramsk presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT martinia presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT ruperton presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis
AT lovelld presfinal2157efficacyofcanakinumabinthetreatmentofsystemicjuvenileidiopathicarthritisa12weekpooledposthocanalysis